Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HIF1-IN-3 (Benzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]-) is an effective inhibitor of HIF-1 (EC50 = 0.9 μM) and can be used in anticancer studies.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 39.00 | |
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 197.00 | |
50 mg | In stock | $ 372.00 | |
100 mg | In stock | $ 511.00 | |
200 mg | In stock | $ 742.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 80.00 |
Description | HIF1-IN-3 (Benzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]-) is an effective inhibitor of HIF-1 (EC50 = 0.9 μM) and can be used in anticancer studies. |
Targets&IC50 | HIF1:0.9 μM (EC50) |
Synonyms | Benzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]- |
Molecular Weight | 412.48 |
Formula | C26H24N2O3 |
CAS No. | 333314-79-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 245 mg/mL (593.97 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HIF1-IN-3 333314-79-7 Angiogenesis Chromatin/Epigenetic HIF Hypoxia-inducible factors HIF1 IN 3 Inhibitor HIFs inhibit HIF-PH HIF1-IN-3 HIF1IN3 Anticancer HIF/HIF Prolyl-Hydroxylase Benzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]- inhibitor